Anti-CGRP antibody preventive treatment of migraine: Practical management

touchCLINICAL PERSPECTIVES for touchNEUROLOGY

Listen to two case-based interviews with migraine specialists focusing on preventive treatment of migraine with anti-CGRP antibodies. In the first, a clinical expert shares his perspectives on treatment failure in patients with migraine, providing insights and guidance, while the second discussion considers different clinical scenarios to focus on practical management.

The experts:

• Prof. Christian Lampl, Konventhospital Barmherzige Brüder, Linz, Austria
• Dr Simy Parikh, Thomas Jefferson University Hospital, Philadelphia, PA, USA

This touchPODCAST is for HCPs only.

This activity is funded by an educational grant from Eli Lilly and Company Limited. This medical education is provided by touchIME.

For further information visit our website:  
https://touchneurology.com/the-role-of-anti-CGRP-antibodies-in-migraine-prevention/